Literature DB >> 28833352

Colorectal cancer in Taiwan: A case-control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment.

Ting-Yu Chiang1,2, Chao-Hui Wang1,3, Yu-Fen Lin1, Jeng-Fu You4,5, Jinn-Shiun Chen4,5, Shu-Ching Chen1,2,6,7.   

Abstract

AIMS: The purposes of this study were to identify the impact of a case management programme on the related factors of refusing treatment or discontinuing treatment in Taiwanese colorectal cancer patients.
BACKGROUND: Side effects of anti-cancer treatments are associated with refusing treatment and discontinuing treatment.
DESIGN: This case-control study, longitudinal database and secondary analysis of population-based data was conducted from 2009-2012.
METHODS: Logistic regression was used to reveal the factors related to refusing or discontinuing treatment.
RESULTS: Of the 68 patients who refused treatment, the top reasons for refusing treatment were patients or their family considered the patients poor physical condition, difficulty in enduring any condition likely to cause physical discomfort from the disease treatment, selected complementary and alternative medicine, patients or their families or friends experienced negative treatment effects and worried about the side effects of treatment, older age, poor family support and lost contact. Of the 278 patients who discontinued treatment, the most common reasons for discontinuing treatment were patients or their families or friends experienced negative treatment effects and worried about the side effects of treatment, inconvenient transportation, patients or their family considered the patients poor physical condition, difficulty in enduring any condition likely to cause physical discomfort from the disease treatment, poor treatment effect and selected complementary and alternative medicine.
CONCLUSION: Case managers can provide positive communication and available resources in relation to cancer treatment. A case management programme can help patients cope with the difficulties encountered during the treatment period.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  anti-cancer treatment; case management; case-control study; colorectal cancer; compliance; decision-making; discontinuing treatment; nursing; refusing treatment; secondary analysis; side effects

Mesh:

Year:  2017        PMID: 28833352     DOI: 10.1111/jan.13443

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  4 in total

1.  Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study.

Authors:  Ya-Lan Chang; Shu-Chu Lee; Chun-Ta Liao; Chao-Hui Wang; Yu-Fen Lin; Shu-Ching Chen
Journal:  Support Care Cancer       Date:  2019-06-08       Impact factor: 3.603

2.  Association Between Thyroid Disorders and Colorectal Cancer Risk in Adult Patients in Taiwan.

Authors:  Abby L'Heureux; Daniel R Wieland; Chien-Huan Weng; Yi-Huei Chen; Ching-Heng Lin; Tseng-Hsi Lin; Chien-Hsiang Weng
Journal:  JAMA Netw Open       Date:  2019-05-03

3.  Clerodane Diterpene Ameliorates Inflammatory Bowel Disease and Potentiates Cell Apoptosis of Colorectal Cancer.

Authors:  Jia-Huei Zheng; Shian-Ren Lin; Feng-Jen Tseng; May-Jywan Tsai; Sheng-I Lue; Yi-Chen Chia; Mindar Woon; Yaw-Syan Fu; Ching-Feng Weng
Journal:  Biomolecules       Date:  2019-11-21

4.  Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan.

Authors:  Nai-Tan Chang; Ying-Hsu Chang; Yu-Tung Huang; Shu-Ching Chen
Journal:  Int J Environ Res Public Health       Date:  2021-01-13       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.